Yaqrit

Index
Globenewswire

Yaqrit Strengthens Funding and Regulatory Capability Ahead of Clinical Trials with Board and Senior Management Team Appointments

Globenewswire

Yaqrit’s HE Candidates Set for Phase 3 as Company Shows Underpinning Data at EASL

Globenewswire

Yaqrit Showcases Clinical Progress at the European Association for the Study of the Liver (EASL) Congress, May 7-10th

Globenewswire

Yaqrit Secures NIHR Grant for Pivotal Trials of its Liver Support Device, DIALIVE, for Patients with Liver Failure

Globenewswire

Yaqrit Strengthens Board and Senior Management Ahead of Multi-prong Clinical Push in Advanced Liver Disease

Globenewswire

Yaqrit Prepares phase 3 for Ammonia Scavenger in Hepatic Encephalopathy

Globenewswire

Yaqrit Appoints New CEO Troels Jordansen to Implement Late Clinical Development and Commercial Strategy